The effect of indomethacin and prostacyclin agonists on blood pressure in a rat model of preeclampsia (Q28376117)

2

0 references

K Chwalisz

3

0 references

Q P Liao

4

0 references

G R Saade

5

0 references

R E Garfield

American Journal of Obstetrics and Gynecology

6

0 references

language of work or name

English

0 references

publication date

May 1999

0 references

published in

0 references

volume

180

0 references

issue

5

0 references

page(s)

1191-5

0 references

cites work

Preeclampsia: an imbalance in placental prostacyclin and thromboxane production

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Low-dose aspirin. II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

N omega-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

In vitro release of endothelium-derived relaxing factor by acetylcholine is increased during the guinea pig pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Nitric oxide activates cyclooxygenase enzymes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

A nitric oxide synthesis inhibitor decreased prostaglandin production in rat mesenteric vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Reduced sensitivity of the renal circulation to angiotensin II in pregnant rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Endothelium-derived relaxing factor inhibition augments vascular angiotensin II reactivity in the pregnant rat hind limb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Prevention of perinatal consequences of pre-eclampsia with low-dose aspirin: results of the epreda trial. The Epreda Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

A Meta-analysis of Low-Dose Aspirin for the Prevention of Pregnancy-Induced Hypertensive Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. ECPPA (Estudo Colaborativo para Prevenção da Pré-eclampsia com Aspirina) Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Effects of thromboxane synthetase inhibitor (OKY-046) on placental blood flow, placental weight and fetal weight in normotensive and spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Thromboxane synthetase inhibition as a new therapy for preeclampsia: animal and human studies minireview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Thromboxane synthetase inhibition in pregnancy-induced hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

Effects of ridogrel on the prostacyclin-thromboxane ratio in nulliparous third trimester-pregnant rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

The possibility of clinical application of the thromboxane A2 synthase inhibitor, ozagrel, for the treatment and prevention of preeclampsia: a preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0

A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2899%2970615-0